Compare · DAVI vs SYK
DAVI vs SYK
Side-by-side comparison of Davion Healthcare Plc (DAVI) and Stryker Corporation (SYK): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DAVI and SYK operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- SYK is the larger of the two at $121.12B, about 4527.7x DAVI ($26.8M).
- SYK has been more active in the news (12 items in the past 4 weeks vs 10 for DAVI).
- SYK has more recent analyst coverage (25 ratings vs 0 for DAVI).
- Company
- Davion Healthcare Plc
- Stryker Corporation
- Price
- -
- -
- Market cap
- $26.8M
- $121.12B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 10
- 12
- Recent ratings
- 0
- 25
Davion Healthcare Plc
Davion Healthcare Plc is a next-generation digital healthcare company developing proprietary, non-invasive health monitoring technologies designed to support the early identification of medical anomalies outside traditional clinical environments. The Company's flagship product, BreastCheck, is an FDA-registered at-home breast health screening test designed to identify potential abnormalities through changes in breast temperature. Davion's broader portfolio includes technologies addressing circulation and foot health, testicular health, skin anomalies, wound monitoring, blood pressure and other areas of preventive healthcare. Davion's growth strategy combines the development and commercialisation of its proprietary technologies with complementary acquisitions intended to expand the Group's product portfolio and commercial, manufacturing and distribution capabilities.
Stryker Corporation
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Latest DAVI
- Amendment: Director Susan M King bought $9,800 worth of shares (10,000 units at $0.98), increasing direct ownership by 200% to 15,000 units (SEC Form 4)
- SEC Form 6-K filed by Davion Healthcare Plc
- Director King Susan M bought $980 worth of shares (10,000 units at $0.10), increasing direct ownership by 200% to 15,000 units (SEC Form 4)
- Director Sluyters Julian bought $26,490 worth of shares (25,000 units at $1.06), increasing direct ownership by 500% to 30,000 units (SEC Form 4)
- Davion Healthcare Plc Provides Shareholders with Guidance on Direct Registration and Confirmation of Share Ownership
- SEC Form 6-K filed by Davion Healthcare Plc
- Davion Healthcare Plc Agrees to Terms in Acquisition of Independence Care Homecare Network
- SEC Form 6-K filed by Davion Healthcare Plc
- SEC Form 6-K filed by Davion Healthcare Plc
- Davion Healthcare Plc Appoints Vienna Capital Partners to Support US$100 Million Acquisition Financing Strategy
Latest SYK
- Director Stryker Ronda E sold $178,924,731 worth of shares (550,000 units at $325.32) (SEC Form 4)
- Stryker Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Stryker announces intention to nominate Jim Davis to board of directors
- What 3.4% GDP Growth and a 4.2% Jobless Rate Say About a Hard Day on Wall Street
- SEC Form S-3ASR filed by Stryker Corporation
- SEC Form IRANNOTICE filed by Stryker Corporation
- SEC Form 10-Q filed by Stryker Corporation
- Stryker downgraded by Canaccord Genuity with a new price target
- SEC Form 8-K filed by Stryker Corporation
- Stryker reports third quarter 2026 operating results